Chamberlain NR 565 Advanced Pharmacology Final Ex… 2026/2027 • Verified • Assured Grade A+
✓ VERIFIED • 2026/2027 UPDATE • 100% ACCURATE
Chamberlain NR 565 Advanced Pharmacology Final Exam
2026/2027 UPDATED |Chamberlain College
ACTUAL EXAM QUESTIONS & VERIFIED ANSWERS
with Clear, Detailed Rationales
Document Type: Exam (Elaborations) / Study Guide
Institution: Chamberlain
Academic Year:
Total Questions: 50 Multiple Choice
Includes: Correct Answers + Rationales
Grade: A+ Assured
ASSURED GRADE A+
Exam (Elaborations) • Detailed Rationales Page 1
,Chamberlain NR 565 Advanced Pharmacology Final Ex… 2026/2027 • Verified • Assured Grade A+
Questions & Verified Answers
1. A 65-year-old patient with chronic kidney disease (CKD) Stage 3 is diagnosed with Type 2
Diabetes. Which of the following considerations is most critical when prescribing
Metformin?
A. Metformin should be started at the maximum dose to ensure rapid glucose control.
B. Metformin is contraindicated if the eGFR is below 30 mL/min/1.73m2.
C. Metformin increases the risk of metabolic alkalosis in renal patients.
D. Stage 3 is diagnosed with Type 2 Diabetes. Which of the following considerations is most critical
when prescribing Metformin?
Answer: B
Rationale: Metformin is contraindicated in patients with an eGFR below 30 mL/min/1.73m2 due to the
increased risk of lactic acidosis. For patients with an eGFR between 30-45, the dose should be
reduced or not initiated. This is important because the nurse must choose the action that keeps the
client safest while still meeting their basic needs. Always think about safety first when answering these
questions. This knowledge supports safe care and helps the nurse teach the client and family clearly
and simply. Clear teaching improves cooperation and reduces anxiety.
2. Which mechanism of action best describes how SGLT2 inhibitors like Empagliflozin
function in managing diabetes?
A. Increasing insulin sensitivity in peripheral tissues.
B. Stimulating the pancreas to release more insulin.
C. Reducing glucose reabsorption in the proximal convoluted tubule of the kidney.
D. Delaying the absorption of carbohydrates in the small intestine.
Answer: C
Rationale: SGLT2 inhibitors block the sodium-glucose cotransporter 2 in the kidneys, leading to
increased urinary glucose excretion. Knowing the reason behind the correct answer makes it easier to
rule out the wrong options quickly. Look for the choice that protects the client and matches the priority
need. Exam questions often test whether you can pick the most practical and safe choice for the client
in real situations. Focus on what the nurse can actually do right now.
Exam (Elaborations) • Detailed Rationales Page 2
, Chamberlain NR 565 Advanced Pharmacology Final Ex… 2026/2027 • Verified • Assured Grade A+
3. When prescribing Amiodarone, which of the following monitoring parameters is essential
due to its potential for long-term toxicity?
A. Pulmonary function tests and thyroid function tests.
B. Serum potassium levels every 2 weeks.
C. Daily weights and intake/output monitoring.
D. Frequent bone density scans.
Answer: A
Rationale: Amiodarone contains iodine and can cause thyroid dysfunction (hyper or hypo) and
pulmonary fibrosis, necessitating baseline and periodic PFTs and TFTs. This is important because the
nurse must choose the action that keeps the client safest while still meeting their basic needs. Always
think about safety first when answering these questions. In practice, this guides the nurse to set
priorities and protect the client from harm. Safety, nutrition, and clear communication are frequent
priorities.
4. A patient taking Warfarin is prescribed Amiodarone for atrial fibrillation. How should the
provider adjust the Warfarin dose?
A. Increase the Warfarin dose by 50% immediately.
B. Maintain the same dose and check INR in a month.
C. Discontinue Warfarin and switch to Aspirin.
D. Decrease the Warfarin dose by approximately 30-50% and monitor INR closely.
Answer: D
Rationale: Amiodarone inhibits CYP2C9, which metabolizes the more potent isomer of Warfarin,
leading to increased INR and bleeding risk. The Warfarin dose should be reduced preemptively.
Remembering this point will help you decide the best nursing action when similar questions appear on
the exam. Link the answer to the client’s current condition and risk level. Remembering this point will
help you decide the best nursing action when similar questions appear on the exam. Link the answer
to the client’s current condition and risk level.
Exam (Elaborations) • Detailed Rationales Page 3
✓ VERIFIED • 2026/2027 UPDATE • 100% ACCURATE
Chamberlain NR 565 Advanced Pharmacology Final Exam
2026/2027 UPDATED |Chamberlain College
ACTUAL EXAM QUESTIONS & VERIFIED ANSWERS
with Clear, Detailed Rationales
Document Type: Exam (Elaborations) / Study Guide
Institution: Chamberlain
Academic Year:
Total Questions: 50 Multiple Choice
Includes: Correct Answers + Rationales
Grade: A+ Assured
ASSURED GRADE A+
Exam (Elaborations) • Detailed Rationales Page 1
,Chamberlain NR 565 Advanced Pharmacology Final Ex… 2026/2027 • Verified • Assured Grade A+
Questions & Verified Answers
1. A 65-year-old patient with chronic kidney disease (CKD) Stage 3 is diagnosed with Type 2
Diabetes. Which of the following considerations is most critical when prescribing
Metformin?
A. Metformin should be started at the maximum dose to ensure rapid glucose control.
B. Metformin is contraindicated if the eGFR is below 30 mL/min/1.73m2.
C. Metformin increases the risk of metabolic alkalosis in renal patients.
D. Stage 3 is diagnosed with Type 2 Diabetes. Which of the following considerations is most critical
when prescribing Metformin?
Answer: B
Rationale: Metformin is contraindicated in patients with an eGFR below 30 mL/min/1.73m2 due to the
increased risk of lactic acidosis. For patients with an eGFR between 30-45, the dose should be
reduced or not initiated. This is important because the nurse must choose the action that keeps the
client safest while still meeting their basic needs. Always think about safety first when answering these
questions. This knowledge supports safe care and helps the nurse teach the client and family clearly
and simply. Clear teaching improves cooperation and reduces anxiety.
2. Which mechanism of action best describes how SGLT2 inhibitors like Empagliflozin
function in managing diabetes?
A. Increasing insulin sensitivity in peripheral tissues.
B. Stimulating the pancreas to release more insulin.
C. Reducing glucose reabsorption in the proximal convoluted tubule of the kidney.
D. Delaying the absorption of carbohydrates in the small intestine.
Answer: C
Rationale: SGLT2 inhibitors block the sodium-glucose cotransporter 2 in the kidneys, leading to
increased urinary glucose excretion. Knowing the reason behind the correct answer makes it easier to
rule out the wrong options quickly. Look for the choice that protects the client and matches the priority
need. Exam questions often test whether you can pick the most practical and safe choice for the client
in real situations. Focus on what the nurse can actually do right now.
Exam (Elaborations) • Detailed Rationales Page 2
, Chamberlain NR 565 Advanced Pharmacology Final Ex… 2026/2027 • Verified • Assured Grade A+
3. When prescribing Amiodarone, which of the following monitoring parameters is essential
due to its potential for long-term toxicity?
A. Pulmonary function tests and thyroid function tests.
B. Serum potassium levels every 2 weeks.
C. Daily weights and intake/output monitoring.
D. Frequent bone density scans.
Answer: A
Rationale: Amiodarone contains iodine and can cause thyroid dysfunction (hyper or hypo) and
pulmonary fibrosis, necessitating baseline and periodic PFTs and TFTs. This is important because the
nurse must choose the action that keeps the client safest while still meeting their basic needs. Always
think about safety first when answering these questions. In practice, this guides the nurse to set
priorities and protect the client from harm. Safety, nutrition, and clear communication are frequent
priorities.
4. A patient taking Warfarin is prescribed Amiodarone for atrial fibrillation. How should the
provider adjust the Warfarin dose?
A. Increase the Warfarin dose by 50% immediately.
B. Maintain the same dose and check INR in a month.
C. Discontinue Warfarin and switch to Aspirin.
D. Decrease the Warfarin dose by approximately 30-50% and monitor INR closely.
Answer: D
Rationale: Amiodarone inhibits CYP2C9, which metabolizes the more potent isomer of Warfarin,
leading to increased INR and bleeding risk. The Warfarin dose should be reduced preemptively.
Remembering this point will help you decide the best nursing action when similar questions appear on
the exam. Link the answer to the client’s current condition and risk level. Remembering this point will
help you decide the best nursing action when similar questions appear on the exam. Link the answer
to the client’s current condition and risk level.
Exam (Elaborations) • Detailed Rationales Page 3
